Rising Prevalence of Chronic Pain and Non-Opioid Innovation Driving Market Growth
Increasing rates of chronic musculoskeletal conditions, rising cancer-related pain, and rapid growth in the global geriatric demographic are driving strong demand across the global Pain Relief Medication Market. Industry evaluations indicate that the market is projected to reach USD 231.54 billion by 2035, exhibiting a robust compound annual growth rate (CAGR) of 7.22%. Academic research...
0 Commenti 0 condivisioni 215 Views 0 Anteprima